Banner - NPPA Connect

Aesthetics

Latest News



Neocutis, San Francisco, is introducing Bio-restorative Skin Cream with PSP. PSP is a proprietary cosmetic ingredient developed at the University of Lausanne, Switzerland. It is the only cosmeceutical product containing the specific natural human growth factors, cytokines and enzymatic antioxidants associated with natural bio-restoration of the skin to promote scarless wound healing. According to the company, the unique formulation of PSP provides skin with the optimal balance of skin nutrients helping to preserve or restore skin when stressed.

Neocutis, San Francisco, is introducing Bio-restorative Skin Cream with PSP. PSP is a proprietary cosmetic ingredient developed at the University of Lausanne, Switzerland. It is the only cosmeceutical product containing the specific natural human growth factors, cytokines and enzymatic antioxidants associated with natural bio-restoration of the skin to promote scarless wound healing. According to the company, the unique formulation of PSP provides skin with the optimal balance of skin nutrients helping to preserve or restore skin when stressed.

WaveLight Laser Technolgie AG of Erlangen, Germany, is introducing three aesthetic lasers to the U.S. market at the 63rd Annual Meeting. Already used in Europe and Asia, the Sinon Q-switched ruby, the Mydon Nd:YAG and the Arion Alexandrite lasers will be Wavelight's first products to enter the U.S. market.

Botulinum toxin type A (Botox Cosmetic, Allergan) can be used safely and effectively in a range of doses to simultaneously treat a spectrum of upper facial rhytids in adult women, but a higher dose provides more marked and more durable efficacy without compromising safety, according to the results of a dose-comparison study presented by Alastair Carruthers, M.D., and Jean Carruthers, M.D.

Boni E. Elewski, M.D., president of the American Academy of Dermatology (AAD), will award the distinguished presidential citation to 20 members today.

Advances in psoriasis

Psoriasis is a chronic skin disorder that affects approximately 2 percent of the U.S. and European population.

As researchers learn more about botulinum toxin, clinicians continue to refine techniques for treating the upper face, especially in male patients.

With the hope of presenting practical advice that can be applied clinically to female patients by dermatologists, experts brought forward issues that consistently require attention, with the focus on one therapy that may forever change leg vein therapy.

Currently, off-label use of highly purified, medical grade 1000-centisoke silicone oil (Silikon 1000, Alcon Laboratories) as a permanent filler material seems to best fulfill the need for persistent, safe, cost-effective and natural-appearing correction.

SkinMedica extends TNS line

SkinMedica, Carlsbad, Calif. is introducing three new products at the 63rd annual meeting.

St. Louis, Mo. — According to a recent survey, hyperhidrosis afflicts nearly 3 percent of the U.S. population, with about half of sufferers experiencing axillary hyperhidrosis and many patients experiencing social, professional and other consequences that often go unaddressed.

Rio de Janeiro, Brazil — Members of the Pigmentary Disorders Academy (PDA) convened here last November for their second annual meeting. While still in its infancy and relatively small in size, the group has already made significant progress as they pursue their mission to optimize care of patients affected by pigmentary disorders.

Kissimmee, Fla. — Four years of data collection on the safety of office-based surgery in Florida provides compelling evidence to support conclusions that plastic surgeons and anesthesiologists are responsible for the majority of all serious complications and deaths due to cosmetic surgery.

Orlando — Cosmetic dermatology may not be the original goal of all young dermatologists going into practice, but as they become more familiar with their field, many may decide to explore the opportunities cosmetic dermatology presents.